Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1184965rdf:typepubmed:Citationlld:pubmed
pubmed-article:1184965lifeskim:mentionsumls-concept:C0024264lld:lifeskim
pubmed-article:1184965lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:1184965lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:1184965lifeskim:mentionsumls-concept:C1318468lld:lifeskim
pubmed-article:1184965lifeskim:mentionsumls-concept:C0036849lld:lifeskim
pubmed-article:1184965lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:1184965lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:1184965lifeskim:mentionsumls-concept:C0439801lld:lifeskim
pubmed-article:1184965lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:1184965lifeskim:mentionsumls-concept:C1511636lld:lifeskim
pubmed-article:1184965lifeskim:mentionsumls-concept:C0079411lld:lifeskim
pubmed-article:1184965lifeskim:mentionsumls-concept:C0521115lld:lifeskim
pubmed-article:1184965lifeskim:mentionsumls-concept:C0002131lld:lifeskim
pubmed-article:1184965pubmed:issue6lld:pubmed
pubmed-article:1184965pubmed:dateCreated1976-2-2lld:pubmed
pubmed-article:1184965pubmed:abstractTextThe conditions for generation of simultaneous and independent cytotoxic lymphocyte (CL) responses to each of two sets of alloantigens of limited cross-reactivity by mouse spleen cells in vitro have been investigated. Responder spleen cells were incubated with mitomycin C-treated C57BL/6 (H-2b) or DBA/2 (H-2d) stimulator spleen cells and day 5 CL responses were assayed with 51Cr-labeled EL-4 leukemia (H-2b) and P815 mastocytoma (H-2d) as target cells. Spleen cells from mice of the various H-2 haplotypes tested differed greatly in their ability to develop specific CL responses against alloantigens on the stimulator spleen cells and in the degree of cross-reactive cytotoxic activity against target cells bearing alloantigens not present on the stimulator spleen cells. In contrast to the other strains examined, DBA/1 (H-2q) spleen cells developed specific CL responses to either H-2b or H-2d alloantigens without exhibiting significant cross-reactive activity on the inappropriate target cell. The CL responses to H-2b and H-2d alloantigens by DBA/1 spleen cells were comparable in magnitude and had similar stimulator cell-dose requirements. Further, DBA/1 spleen cells developed CL responses of normal magnitude simultaneously against both target cells when incubated with both mitomycin C-treated C57BL/6 and DBA/2 stimulator cells.lld:pubmed
pubmed-article:1184965pubmed:languageenglld:pubmed
pubmed-article:1184965pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1184965pubmed:citationSubsetAIMlld:pubmed
pubmed-article:1184965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1184965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1184965pubmed:statusMEDLINElld:pubmed
pubmed-article:1184965pubmed:monthDeclld:pubmed
pubmed-article:1184965pubmed:issn0022-1767lld:pubmed
pubmed-article:1184965pubmed:authorpubmed-author:PierceC WCWlld:pubmed
pubmed-article:1184965pubmed:authorpubmed-author:PeavyD LDLlld:pubmed
pubmed-article:1184965pubmed:issnTypePrintlld:pubmed
pubmed-article:1184965pubmed:volume115lld:pubmed
pubmed-article:1184965pubmed:ownerNLMlld:pubmed
pubmed-article:1184965pubmed:authorsCompleteYlld:pubmed
pubmed-article:1184965pubmed:pagination1515-20lld:pubmed
pubmed-article:1184965pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1184965pubmed:meshHeadingpubmed-meshheading:1184965-...lld:pubmed
pubmed-article:1184965pubmed:meshHeadingpubmed-meshheading:1184965-...lld:pubmed
pubmed-article:1184965pubmed:meshHeadingpubmed-meshheading:1184965-...lld:pubmed
pubmed-article:1184965pubmed:meshHeadingpubmed-meshheading:1184965-...lld:pubmed
pubmed-article:1184965pubmed:meshHeadingpubmed-meshheading:1184965-...lld:pubmed
pubmed-article:1184965pubmed:meshHeadingpubmed-meshheading:1184965-...lld:pubmed
pubmed-article:1184965pubmed:meshHeadingpubmed-meshheading:1184965-...lld:pubmed
pubmed-article:1184965pubmed:meshHeadingpubmed-meshheading:1184965-...lld:pubmed
pubmed-article:1184965pubmed:meshHeadingpubmed-meshheading:1184965-...lld:pubmed
pubmed-article:1184965pubmed:meshHeadingpubmed-meshheading:1184965-...lld:pubmed
pubmed-article:1184965pubmed:meshHeadingpubmed-meshheading:1184965-...lld:pubmed
pubmed-article:1184965pubmed:meshHeadingpubmed-meshheading:1184965-...lld:pubmed
pubmed-article:1184965pubmed:meshHeadingpubmed-meshheading:1184965-...lld:pubmed
pubmed-article:1184965pubmed:meshHeadingpubmed-meshheading:1184965-...lld:pubmed
pubmed-article:1184965pubmed:year1975lld:pubmed
pubmed-article:1184965pubmed:articleTitleCell-mediated immune responses in vitro. II. Simultaneous generation of cytotoxic lymphocyte responses to two sets of alloantigens of limited cross-reactivity.lld:pubmed
pubmed-article:1184965pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1184965pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1184965lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1184965lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1184965lld:pubmed